Abstract
Three cases of multiple myeloma treated with thalidomide are presented which highlight therapeutic dilemmas presented by therapy with this new agent. The difficulty of stem cell collection during thalidomide therapy is illustrated. The question of continuation of thalidomide after attainment of a plateau or remission is discussed and the management of neuropathy considered. Thalidomide, being a novel drug, presents a number of therapeutic issues that have yet to be resolved.
| Original language | English |
|---|---|
| Pages (from-to) | 593-596 |
| Number of pages | 4 |
| Journal | Seminars in Oncology |
| Volume | 28 |
| Issue number | 6 |
| DOIs | |
| State | Published - 2001 |
| Externally published | Yes |
Fingerprint
Dive into the research topics of 'Therapeutic dilemmas with thalidomide in multiple myeloma: Case discussions'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver